Gene Symbol | Gene ID | Gene Info |
---|---|---|
MEIS1
|
ENSG00000143995.15 | Meis homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_66800716_66800867 | MEIS1 | 64732 | 0.132604 | 0.81 | 8.3e-03 | Click! |
chr2_67157367_67157518 | MEIS1 | 421383 | 0.006713 | 0.60 | 9.1e-02 | Click! |
chr2_66803645_66804000 | MEIS1 | 67763 | 0.126743 | 0.56 | 1.2e-01 | Click! |
chr2_66735557_66735708 | MEIS1 | 427 | 0.877982 | 0.53 | 1.4e-01 | Click! |
chr2_66662081_66662232 | MEIS1 | 109 | 0.946260 | -0.51 | 1.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_640288_641115 | 1.10 |
RAB40C |
RAB40C, member RAS oncogene family |
369 |
0.68 |
chr20_10286915_10287750 | 0.73 |
ENSG00000211588 |
. |
55546 |
0.13 |
chr8_128919529_128920109 | 0.73 |
TMEM75 |
transmembrane protein 75 |
40772 |
0.15 |
chr9_34651822_34652525 | 0.70 |
IL11RA |
interleukin 11 receptor, alpha |
16 |
0.94 |
chr9_96214890_96215815 | 0.61 |
FAM120AOS |
family with sequence similarity 120A opposite strand |
522 |
0.51 |
chr17_17726041_17726867 | 0.59 |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
478 |
0.73 |
chr1_14924992_14926197 | 0.58 |
KAZN |
kazrin, periplakin interacting protein |
381 |
0.93 |
chr1_78468921_78469158 | 0.56 |
RP11-386I14.4 |
|
1199 |
0.35 |
chr20_22384501_22385014 | 0.54 |
FOXA2 |
forkhead box A2 |
180344 |
0.03 |
chr4_157692811_157693135 | 0.53 |
RP11-154F14.2 |
|
69538 |
0.11 |
chr5_37736234_37736424 | 0.53 |
ENSG00000206743 |
. |
35790 |
0.19 |
chr21_35678304_35678597 | 0.51 |
ENSG00000266007 |
. |
1020 |
0.57 |
chr1_26704591_26705236 | 0.51 |
ZNF683 |
zinc finger protein 683 |
3900 |
0.15 |
chr9_109459969_109460612 | 0.49 |
ENSG00000200131 |
. |
18032 |
0.28 |
chr5_134727497_134727842 | 0.48 |
H2AFY |
H2A histone family, member Y |
7232 |
0.17 |
chr19_5802056_5802207 | 0.48 |
DUS3L |
dihydrouridine synthase 3-like (S. cerevisiae) |
10882 |
0.09 |
chr5_171380881_171381289 | 0.48 |
FBXW11 |
F-box and WD repeat domain containing 11 |
23675 |
0.23 |
chr2_84282857_84283143 | 0.47 |
ENSG00000252298 |
. |
197053 |
0.03 |
chr8_42063953_42065062 | 0.47 |
PLAT |
plasminogen activator, tissue |
576 |
0.71 |
chr1_172360185_172360576 | 0.47 |
DNM3 |
dynamin 3 |
12222 |
0.16 |
chr16_87469465_87469755 | 0.47 |
ZCCHC14 |
zinc finger, CCHC domain containing 14 |
2870 |
0.22 |
chr20_55204347_55205219 | 0.47 |
TFAP2C |
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) |
425 |
0.81 |
chr9_113342240_113342458 | 0.46 |
SVEP1 |
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
189 |
0.96 |
chr19_19174720_19175940 | 0.45 |
SLC25A42 |
solute carrier family 25, member 42 |
522 |
0.7 |
chr1_68149030_68149645 | 0.45 |
GADD45A |
growth arrest and DNA-damage-inducible, alpha |
1407 |
0.47 |
chr9_14180845_14181011 | 0.44 |
NFIB |
nuclear factor I/B |
131 |
0.98 |
chr5_167266384_167266535 | 0.44 |
ENSG00000221741 |
. |
31211 |
0.18 |
chr20_16514306_16514457 | 0.44 |
KIF16B |
kinesin family member 16B |
39697 |
0.2 |
chr13_30251628_30251779 | 0.44 |
SLC7A1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
81878 |
0.11 |
chr13_56670560_56670711 | 0.44 |
ENSG00000238455 |
. |
463123 |
0.01 |
chr5_1315874_1316496 | 0.44 |
ENSG00000263670 |
. |
6693 |
0.18 |
chr18_54318050_54319471 | 0.43 |
TXNL1 |
thioredoxin-like 1 |
64 |
0.61 |
chr12_66122461_66123138 | 0.43 |
HMGA2 |
high mobility group AT-hook 2 |
95112 |
0.08 |
chr19_13107353_13108160 | 0.43 |
NFIX |
nuclear factor I/X (CCAAT-binding transcription factor) |
1104 |
0.3 |
chr11_10695962_10696877 | 0.43 |
MRVI1 |
murine retrovirus integration site 1 homolog |
18642 |
0.17 |
chr1_183156151_183156302 | 0.43 |
LAMC2 |
laminin, gamma 2 |
803 |
0.7 |
chrX_73755392_73756724 | 0.42 |
SLC16A2 |
solute carrier family 16, member 2 (thyroid hormone transporter) |
15103 |
0.23 |
chr1_210465594_210466382 | 0.42 |
HHAT |
hedgehog acyltransferase |
35608 |
0.17 |
chr15_48010788_48011252 | 0.42 |
SEMA6D |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
334 |
0.93 |
chr19_54676940_54677234 | 0.42 |
TMC4 |
transmembrane channel-like 4 |
143 |
0.89 |
chr1_161195725_161196723 | 0.42 |
TOMM40L |
translocase of outer mitochondrial membrane 40 homolog (yeast)-like |
130 |
0.84 |
chr17_46129068_46130070 | 0.41 |
NFE2L1 |
nuclear factor, erythroid 2-like 1 |
2121 |
0.15 |
chr6_13761461_13761614 | 0.41 |
MCUR1 |
mitochondrial calcium uniporter regulator 1 |
40040 |
0.15 |
chr9_86916681_86916945 | 0.41 |
RP11-380F14.2 |
|
23679 |
0.22 |
chr10_72163983_72165283 | 0.40 |
EIF4EBP2 |
eukaryotic translation initiation factor 4E binding protein 2 |
498 |
0.77 |
chr13_35962874_35963128 | 0.40 |
MAB21L1 |
mab-21-like 1 (C. elegans) |
87831 |
0.09 |
chr5_95294796_95295032 | 0.40 |
ELL2 |
elongation factor, RNA polymerase II, 2 |
2638 |
0.26 |
chr7_33972032_33972255 | 0.40 |
BMPER |
BMP binding endothelial regulator |
26998 |
0.26 |
chr2_145732023_145732174 | 0.39 |
ENSG00000253036 |
. |
360540 |
0.01 |
chr3_132349108_132349259 | 0.39 |
UBA5 |
ubiquitin-like modifier activating enzyme 5 |
24107 |
0.16 |
chr22_43042721_43042986 | 0.39 |
CYB5R3 |
cytochrome b5 reductase 3 |
113 |
0.95 |
chr7_32110576_32110834 | 0.39 |
PDE1C |
phosphodiesterase 1C, calmodulin-dependent 70kDa |
231 |
0.97 |
chr1_50489142_50489611 | 0.39 |
AGBL4 |
ATP/GTP binding protein-like 4 |
196 |
0.94 |
chr6_72129322_72130506 | 0.39 |
ENSG00000207827 |
. |
16590 |
0.22 |
chr6_71108128_71108412 | 0.38 |
FAM135A |
family with sequence similarity 135, member A |
14741 |
0.21 |
chr1_200749440_200749639 | 0.38 |
CAMSAP2 |
calmodulin regulated spectrin-associated protein family, member 2 |
40632 |
0.17 |
chr1_239302822_239302973 | 0.38 |
CHRM3 |
cholinergic receptor, muscarinic 3 |
489476 |
0.01 |
chr15_95739591_95739742 | 0.38 |
ENSG00000222076 |
. |
549367 |
0.0 |
chr1_151174318_151174695 | 0.38 |
PIP5K1A |
phosphatidylinositol-4-phosphate 5-kinase, type I, alpha |
3455 |
0.12 |
chr3_192535250_192535401 | 0.38 |
FGF12 |
fibroblast growth factor 12 |
49772 |
0.16 |
chr21_32715523_32716836 | 0.38 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
415 |
0.91 |
chr16_75121726_75121965 | 0.37 |
ZNRF1 |
zinc and ring finger 1, E3 ubiquitin protein ligase |
16837 |
0.15 |
chr11_7599067_7599755 | 0.37 |
PPFIBP2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
1140 |
0.49 |
chr2_24123591_24123937 | 0.37 |
ATAD2B |
ATPase family, AAA domain containing 2B |
26171 |
0.17 |
chr6_91500118_91500269 | 0.37 |
MAP3K7 |
mitogen-activated protein kinase kinase kinase 7 |
203429 |
0.03 |
chr14_105436556_105437076 | 0.37 |
AHNAK2 |
AHNAK nucleoprotein 2 |
7878 |
0.16 |
chr18_30049396_30050442 | 0.37 |
GAREM |
GRB2 associated, regulator of MAPK1 |
476 |
0.87 |
chr7_33946724_33946875 | 0.37 |
BMPER |
BMP binding endothelial regulator |
1654 |
0.54 |
chr18_24736144_24736295 | 0.36 |
CHST9 |
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 9 |
13217 |
0.31 |
chr12_95509986_95510137 | 0.36 |
FGD6 |
FYVE, RhoGEF and PH domain containing 6 |
688 |
0.74 |
chr9_110250307_110251795 | 0.36 |
KLF4 |
Kruppel-like factor 4 (gut) |
360 |
0.89 |
chr15_82185842_82186054 | 0.36 |
ENSG00000222521 |
. |
150687 |
0.04 |
chr6_106982104_106982255 | 0.36 |
AIM1 |
absent in melanoma 1 |
6830 |
0.22 |
chr2_29337699_29338221 | 0.36 |
CLIP4 |
CAP-GLY domain containing linker protein family, member 4 |
332 |
0.87 |
chr3_172303826_172303977 | 0.36 |
AC007919.2 |
HCG1787166; PRO1163; Uncharacterized protein |
57582 |
0.11 |
chr15_47476270_47477144 | 0.36 |
SEMA6D |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
409 |
0.87 |
chr12_67807670_67807821 | 0.36 |
CAND1 |
cullin-associated and neddylation-dissociated 1 |
114993 |
0.07 |
chr22_30658388_30658630 | 0.36 |
OSM |
oncostatin M |
3298 |
0.13 |
chr2_43822335_43823890 | 0.35 |
THADA |
thyroid adenoma associated |
1 |
0.98 |
chr20_39945349_39946123 | 0.35 |
ZHX3 |
zinc fingers and homeoboxes 3 |
90 |
0.97 |
chr12_15600082_15600233 | 0.35 |
RERG |
RAS-like, estrogen-regulated, growth inhibitor |
98625 |
0.08 |
chr7_124430606_124430965 | 0.35 |
GPR37 |
G protein-coupled receptor 37 (endothelin receptor type B-like) |
25104 |
0.22 |
chr13_60580593_60580744 | 0.35 |
DIAPH3-AS1 |
DIAPH3 antisense RNA 1 |
6217 |
0.26 |
chr1_115153328_115153616 | 0.35 |
BCAS2 |
breast carcinoma amplified sequence 2 |
29212 |
0.16 |
chr12_69418432_69418757 | 0.35 |
CPM |
carboxypeptidase M |
61545 |
0.11 |
chr11_8832812_8833111 | 0.35 |
ST5 |
suppression of tumorigenicity 5 |
73 |
0.96 |
chr14_21081225_21081433 | 0.35 |
RNASE11 |
ribonuclease, RNase A family, 11 (non-active) |
3286 |
0.14 |
chr17_78866297_78866787 | 0.34 |
RPTOR |
regulatory associated protein of MTOR, complex 1 |
29982 |
0.14 |
chr12_59472769_59472920 | 0.34 |
RP11-150C16.1 |
|
158424 |
0.04 |
chr16_49150769_49150920 | 0.34 |
CBLN1 |
cerebellin 1 precursor |
164629 |
0.04 |
chr20_15793445_15793596 | 0.34 |
MACROD2 |
MACRO domain containing 2 |
49930 |
0.19 |
chr6_33610158_33610417 | 0.34 |
ITPR3 |
inositol 1,4,5-trisphosphate receptor, type 3 |
21126 |
0.13 |
chr17_38178315_38178466 | 0.34 |
MED24 |
mediator complex subunit 24 |
1023 |
0.38 |
chr14_45559377_45559745 | 0.34 |
ENSG00000212615 |
. |
2115 |
0.2 |
chr13_33791465_33791616 | 0.34 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
11397 |
0.23 |
chr6_36645350_36645501 | 0.34 |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
163 |
0.94 |
chr12_54391177_54391923 | 0.34 |
HOXC-AS2 |
HOXC cluster antisense RNA 2 |
981 |
0.22 |
chr10_104069935_104070086 | 0.34 |
ENSG00000251989 |
. |
49023 |
0.09 |
chr11_120271300_120271503 | 0.33 |
ARHGEF12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
15398 |
0.2 |
chr2_29548877_29549028 | 0.33 |
ALK |
anaplastic lymphoma receptor tyrosine kinase |
102692 |
0.07 |
chr9_73095232_73095769 | 0.33 |
KLF9 |
Kruppel-like factor 9 |
65960 |
0.12 |
chr3_79432526_79432918 | 0.33 |
ENSG00000265193 |
. |
124315 |
0.06 |
chr1_66998527_66999432 | 0.33 |
SGIP1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
87 |
0.98 |
chr9_102021888_102022109 | 0.33 |
ENSG00000222337 |
. |
24306 |
0.17 |
chr7_30189174_30189325 | 0.33 |
MTURN |
maturin, neural progenitor differentiation regulator homolog (Xenopus) |
3736 |
0.2 |
chr12_58704955_58705136 | 0.33 |
RP11-362K2.2 |
Protein LOC100506869 |
232862 |
0.02 |
chr12_1423709_1423860 | 0.33 |
RP5-951N9.2 |
|
71215 |
0.1 |
chr4_107956832_107957922 | 0.32 |
DKK2 |
dickkopf WNT signaling pathway inhibitor 2 |
77 |
0.99 |
chr13_99641281_99641432 | 0.32 |
DOCK9 |
dedicator of cytokinesis 9 |
11018 |
0.23 |
chr5_157861845_157861996 | 0.32 |
ENSG00000222626 |
. |
457956 |
0.01 |
chr6_44195015_44195399 | 0.32 |
SLC29A1 |
solute carrier family 29 (equilibrative nucleoside transporter), member 1 |
331 |
0.82 |
chr1_32421860_32422231 | 0.32 |
PTP4A2 |
protein tyrosine phosphatase type IVA, member 2 |
13868 |
0.17 |
chr4_181055224_181055668 | 0.32 |
NA |
NA |
> 106 |
NA |
chr1_33168933_33169118 | 0.32 |
SYNC |
syncoilin, intermediate filament protein |
172 |
0.93 |
chr3_133524639_133525577 | 0.32 |
SRPRB |
signal recognition particle receptor, B subunit |
649 |
0.75 |
chr1_90184902_90185053 | 0.32 |
ENSG00000239176 |
. |
48900 |
0.13 |
chr15_67390777_67391884 | 0.32 |
SMAD3 |
SMAD family member 3 |
313 |
0.93 |
chr17_33391542_33391948 | 0.32 |
RFFL |
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase |
874 |
0.45 |
chr17_45198216_45198367 | 0.32 |
ENSG00000221016 |
. |
2423 |
0.23 |
chr2_198464213_198464591 | 0.32 |
RFTN2 |
raftlin family member 2 |
18217 |
0.19 |
chr4_47851555_47851706 | 0.32 |
CORIN |
corin, serine peptidase |
11507 |
0.21 |
chr1_158087708_158088406 | 0.32 |
KIRREL |
kin of IRRE like (Drosophila) |
31587 |
0.18 |
chr10_77168132_77169350 | 0.32 |
ENSG00000237149 |
. |
5929 |
0.2 |
chr6_19838575_19839711 | 0.32 |
RP1-167F1.2 |
|
168 |
0.95 |
chr7_132260669_132261651 | 0.32 |
PLXNA4 |
plexin A4 |
69 |
0.98 |
chr13_105442959_105443110 | 0.32 |
DAOA |
D-amino acid oxidase activator |
675558 |
0.0 |
chr4_125725281_125725432 | 0.32 |
ANKRD50 |
ankyrin repeat domain 50 |
91469 |
0.1 |
chr17_64464860_64465690 | 0.32 |
RP11-4F22.2 |
|
52303 |
0.15 |
chr2_17994561_17995135 | 0.32 |
MSGN1 |
mesogenin 1 |
2915 |
0.27 |
chr6_75634606_75634757 | 0.31 |
COL12A1 |
collagen, type XII, alpha 1 |
194093 |
0.03 |
chr10_46010179_46010570 | 0.31 |
MARCH8 |
membrane-associated ring finger (C3HC4) 8, E3 ubiquitin protein ligase |
20445 |
0.22 |
chr1_209393485_209393990 | 0.31 |
ENSG00000230937 |
. |
211741 |
0.02 |
chr7_67474743_67474894 | 0.31 |
ENSG00000265600 |
. |
653151 |
0.0 |
chr10_112113893_112114201 | 0.31 |
SMNDC1 |
survival motor neuron domain containing 1 |
49338 |
0.14 |
chr14_102050713_102051023 | 0.31 |
DIO3 |
deiodinase, iodothyronine, type III |
23180 |
0.17 |
chr7_129598360_129598651 | 0.31 |
ENSG00000207184 |
. |
3411 |
0.15 |
chr10_103326247_103326406 | 0.31 |
DPCD |
deleted in primary ciliary dyskinesia homolog (mouse) |
4080 |
0.2 |
chr7_26126830_26127131 | 0.31 |
ENSG00000266430 |
. |
27021 |
0.2 |
chr2_169377724_169378182 | 0.31 |
ENSG00000265694 |
. |
61500 |
0.1 |
chr7_115912354_115912783 | 0.31 |
TES |
testis derived transcript (3 LIM domains) |
22079 |
0.19 |
chr17_37183284_37183583 | 0.31 |
LRRC37A11P |
leucine rich repeat containing 37, member A11, pseudogene |
97 |
0.96 |
chr3_9745623_9746706 | 0.31 |
CPNE9 |
copine family member IX |
654 |
0.62 |
chr6_166795582_166796398 | 0.31 |
MPC1 |
mitochondrial pyruvate carrier 1 |
496 |
0.56 |
chr1_27443108_27443302 | 0.31 |
SLC9A1 |
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
37768 |
0.14 |
chr1_44030641_44030792 | 0.31 |
PTPRF |
protein tyrosine phosphatase, receptor type, F |
19969 |
0.18 |
chr2_174000750_174001454 | 0.31 |
MLTK |
Mitogen-activated protein kinase kinase kinase MLT |
45755 |
0.16 |
chr21_30502885_30503196 | 0.31 |
MAP3K7CL |
MAP3K7 C-terminal like |
81 |
0.96 |
chr16_14398873_14399280 | 0.31 |
ENSG00000207639 |
. |
1252 |
0.44 |
chr12_102040565_102040734 | 0.31 |
RP11-755O11.2 |
|
4077 |
0.2 |
chr20_5712743_5712894 | 0.31 |
C20orf196 |
chromosome 20 open reading frame 196 |
18221 |
0.25 |
chr1_165602062_165602213 | 0.31 |
MGST3 |
microsomal glutathione S-transferase 3 |
660 |
0.71 |
chr12_19270446_19270597 | 0.31 |
PLEKHA5 |
pleckstrin homology domain containing, family A member 5 |
12127 |
0.23 |
chr2_237551540_237552008 | 0.30 |
ACKR3 |
atypical chemokine receptor 3 |
73490 |
0.12 |
chr9_139886935_139887950 | 0.30 |
C9orf142 |
chromosome 9 open reading frame 142 |
572 |
0.45 |
chr2_102359188_102359339 | 0.30 |
MAP4K4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
44271 |
0.19 |
chr15_72529055_72529849 | 0.30 |
PKM |
pyruvate kinase, muscle |
5288 |
0.17 |
chr5_124202427_124202671 | 0.30 |
ZNF608 |
zinc finger protein 608 |
118049 |
0.05 |
chr1_9653728_9653879 | 0.30 |
TMEM201 |
transmembrane protein 201 |
3152 |
0.26 |
chr7_148232370_148232768 | 0.30 |
C7orf33 |
chromosome 7 open reading frame 33 |
55088 |
0.14 |
chr10_76249005_76249156 | 0.30 |
RP11-46O21.2 |
|
39996 |
0.19 |
chr5_58830530_58830681 | 0.30 |
PDE4D |
phosphodiesterase 4D, cAMP-specific |
51614 |
0.19 |
chr10_123357016_123357770 | 0.30 |
FGFR2 |
fibroblast growth factor receptor 2 |
205 |
0.97 |
chr2_218560010_218560412 | 0.30 |
DIRC3 |
disrupted in renal carcinoma 3 |
61067 |
0.14 |
chr1_31407482_31407633 | 0.30 |
ENSG00000200154 |
. |
1063 |
0.44 |
chr1_19973947_19974889 | 0.30 |
NBL1 |
neuroblastoma 1, DAN family BMP antagonist |
314 |
0.87 |
chr7_48125773_48125924 | 0.30 |
UPP1 |
uridine phosphorylase 1 |
2377 |
0.33 |
chr18_29030114_29030410 | 0.30 |
DSG3 |
desmoglein 3 |
2504 |
0.25 |
chr9_90588787_90589959 | 0.30 |
CDK20 |
cyclin-dependent kinase 20 |
29 |
0.98 |
chr13_114559546_114559768 | 0.30 |
GAS6 |
growth arrest-specific 6 |
7383 |
0.25 |
chr2_28939308_28939670 | 0.30 |
AC097724.3 |
|
19486 |
0.15 |
chr5_57134719_57134870 | 0.30 |
ENSG00000266864 |
. |
34079 |
0.24 |
chr20_19915434_19915955 | 0.30 |
RIN2 |
Ras and Rab interactor 2 |
45484 |
0.16 |
chr3_112964540_112964768 | 0.30 |
BOC |
BOC cell adhesion associated, oncogene regulated |
29456 |
0.19 |
chr6_86113057_86113246 | 0.30 |
NT5E |
5'-nucleotidase, ecto (CD73) |
46658 |
0.19 |
chr10_35060387_35060538 | 0.30 |
PARD3 |
par-3 family cell polarity regulator |
43787 |
0.16 |
chr6_67228735_67228886 | 0.30 |
ENSG00000221281 |
. |
159492 |
0.04 |
chr14_85707273_85707789 | 0.30 |
ENSG00000252529 |
. |
30745 |
0.26 |
chr13_24782165_24782389 | 0.29 |
SPATA13 |
spermatogenesis associated 13 |
43555 |
0.13 |
chr9_18689231_18689382 | 0.29 |
ENSG00000252960 |
. |
38161 |
0.2 |
chr17_29020953_29021202 | 0.29 |
ENSG00000241631 |
. |
8716 |
0.17 |
chr4_57974006_57974157 | 0.29 |
ENSG00000238541 |
. |
1570 |
0.29 |
chr22_46462951_46463814 | 0.29 |
RP6-109B7.4 |
|
2389 |
0.16 |
chr18_46460407_46461027 | 0.29 |
SMAD7 |
SMAD family member 7 |
14158 |
0.24 |
chr3_184037306_184037783 | 0.29 |
EIF4G1 |
eukaryotic translation initiation factor 4 gamma, 1 |
1 |
0.95 |
chr2_182760406_182760853 | 0.29 |
SSFA2 |
sperm specific antigen 2 |
3706 |
0.25 |
chr14_37570606_37570757 | 0.29 |
RP11-537P22.2 |
|
2913 |
0.31 |
chr17_72008631_72008782 | 0.29 |
RPL38 |
ribosomal protein L38 |
191015 |
0.02 |
chr1_214397865_214398571 | 0.29 |
SMYD2 |
SET and MYND domain containing 2 |
56358 |
0.16 |
chr17_74442541_74443075 | 0.29 |
UBE2O |
ubiquitin-conjugating enzyme E2O |
6480 |
0.12 |
chr13_107540716_107540867 | 0.29 |
ENSG00000239050 |
. |
86583 |
0.11 |
chr1_113933852_113934516 | 0.29 |
MAGI3 |
membrane associated guanylate kinase, WW and PDZ domain containing 3 |
573 |
0.86 |
chr10_115860454_115861476 | 0.29 |
ENSG00000253066 |
. |
10208 |
0.2 |
chr8_144099091_144099248 | 0.29 |
LY6E |
lymphocyte antigen 6 complex, locus E |
230 |
0.93 |
chr6_158090942_158091198 | 0.29 |
ZDHHC14 |
zinc finger, DHHC-type containing 14 |
77029 |
0.1 |
chr2_70994239_70995345 | 0.29 |
ADD2 |
adducin 2 (beta) |
55 |
0.97 |
chr13_114527173_114527324 | 0.29 |
GAS6-AS1 |
GAS6 antisense RNA 1 |
8645 |
0.21 |
chr9_112839583_112839734 | 0.29 |
AKAP2 |
A kinase (PRKA) anchor protein 2 |
12819 |
0.28 |
chr2_153211288_153211531 | 0.29 |
FMNL2 |
formin-like 2 |
19658 |
0.26 |
chr7_36566798_36566949 | 0.29 |
AC006960.7 |
|
64241 |
0.1 |
chr3_186335083_186335441 | 0.29 |
AHSG |
alpha-2-HS-glycoprotein |
4407 |
0.15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.9 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.3 | 0.5 | GO:0035844 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.2 | 0.7 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.7 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 0.4 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.2 | 0.2 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.2 | 0.3 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.2 | 1.3 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 0.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.6 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.1 | 0.4 | GO:0044415 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 1.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.1 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 0.5 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.4 | GO:0003181 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
0.1 | 0.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.3 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
0.1 | 0.3 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.3 | GO:0060426 | lung vasculature development(GO:0060426) |
0.1 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.1 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 1.0 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.1 | GO:0051280 | negative regulation of ion transmembrane transporter activity(GO:0032413) negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.1 | 0.3 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.1 | 0.4 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 1.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.3 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.1 | 0.4 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.1 | 0.7 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.1 | 0.5 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.3 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.3 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.1 | 0.1 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.1 | 0.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.2 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.3 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.3 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.3 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.1 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.4 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.1 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.1 | 0.4 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.3 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.5 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 0.3 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.1 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.1 | 0.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.2 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.1 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.2 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.1 | 0.5 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.1 | 0.1 | GO:0070100 | regulation of chemokine-mediated signaling pathway(GO:0070099) negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.1 | 0.2 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.1 | GO:0098810 | neurotransmitter reuptake(GO:0098810) |
0.1 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.1 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.1 | 0.3 | GO:0048242 | epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
0.1 | 0.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.4 | GO:1902667 | regulation of axon guidance(GO:1902667) |
0.1 | 0.4 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.1 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.1 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.1 | 0.2 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.1 | 0.4 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.1 | 0.3 | GO:0032933 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.2 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 0.2 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.1 | 0.1 | GO:0006991 | response to sterol depletion(GO:0006991) |
0.1 | 0.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.2 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.1 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.1 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
0.1 | 0.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.2 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.1 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
0.1 | 0.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.2 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 0.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.2 | GO:0010716 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.1 | GO:0090030 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) regulation of steroid hormone biosynthetic process(GO:0090030) |
0.1 | 1.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.1 | GO:0003179 | heart valve development(GO:0003170) heart valve morphogenesis(GO:0003179) |
0.1 | 0.3 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.1 | GO:0060438 | trachea development(GO:0060438) |
0.1 | 0.2 | GO:0006533 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.1 | 0.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.3 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.1 | 0.2 | GO:0048865 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.1 | 0.1 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.1 | 0.3 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.1 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 0.3 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.1 | 0.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.9 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.8 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 0.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.1 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.1 | 0.1 | GO:0033088 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.1 | GO:2000737 | negative regulation of stem cell differentiation(GO:2000737) |
0.1 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.1 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.1 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.0 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.0 | GO:0007442 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.0 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.1 | GO:0021546 | rhombomere development(GO:0021546) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.1 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.0 | 0.1 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.0 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.1 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.0 | 0.2 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.0 | 0.1 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.0 | 0.0 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.1 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.0 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.0 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.0 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0008049 | male courtship behavior(GO:0008049) |
0.0 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.2 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.0 | 0.2 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.0 | 4.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.0 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.0 | 0.1 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.0 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.3 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.1 | GO:0060044 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.0 | 0.6 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.1 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.1 | GO:1900116 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.1 | GO:0090037 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 0.2 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.4 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.3 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.0 | 0.1 | GO:0061299 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.3 | GO:0031649 | heat generation(GO:0031649) |
0.0 | 0.8 | GO:0046068 | cGMP metabolic process(GO:0046068) |
0.0 | 0.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.0 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.0 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.3 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.0 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.0 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.1 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.1 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.2 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.0 | 0.1 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.0 | 0.2 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.2 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.0 | 0.1 | GO:0033197 | response to vitamin E(GO:0033197) |
0.0 | 0.0 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.1 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.5 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.0 | 0.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.2 | GO:0031272 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.0 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.0 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.0 | 0.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.0 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.0 | 0.2 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.0 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.1 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.0 | 0.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.1 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.0 | 0.0 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.1 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.0 | 0.9 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.0 | GO:0060065 | uterus development(GO:0060065) cornea development in camera-type eye(GO:0061303) |
0.0 | 0.1 | GO:0010656 | negative regulation of muscle cell apoptotic process(GO:0010656) |
0.0 | 0.1 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.1 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.4 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.1 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.1 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.0 | 0.0 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.0 | 0.0 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.0 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.0 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.0 | 0.1 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.0 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.0 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.0 | 0.0 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.3 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.0 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.0 | 0.1 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.0 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.0 | 0.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.9 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.0 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.1 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.0 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.1 | GO:0072210 | metanephric nephron development(GO:0072210) |
0.0 | 0.1 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.0 | 0.0 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.0 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.3 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.2 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.1 | GO:0007549 | dosage compensation(GO:0007549) |
0.0 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.0 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.0 | 0.1 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.0 | 0.0 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.1 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.0 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.0 | 0.1 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.0 | 0.1 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.0 | GO:0048486 | parasympathetic nervous system development(GO:0048486) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.1 | GO:1901862 | negative regulation of muscle tissue development(GO:1901862) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.2 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
0.0 | 0.1 | GO:0071384 | cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
0.0 | 0.1 | GO:0002857 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.0 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.1 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.4 | GO:0048675 | axon extension(GO:0048675) neuron projection extension(GO:1990138) |
0.0 | 0.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.1 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.0 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.2 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.0 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.2 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.0 | 0.2 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.0 | 0.0 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.0 | 0.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.0 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 0.0 | GO:0003071 | renal system process involved in regulation of blood volume(GO:0001977) renal system process involved in regulation of systemic arterial blood pressure(GO:0003071) |
0.0 | 0.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.0 | GO:0071503 | response to heparin(GO:0071503) |
0.0 | 0.2 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.0 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.0 | 0.1 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.1 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.0 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 0.0 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.0 | GO:0019614 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 0.0 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.1 | GO:0010771 | negative regulation of cell morphogenesis involved in differentiation(GO:0010771) |
0.0 | 0.1 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.0 | 0.0 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.0 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.0 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.1 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.1 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.0 | 0.0 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.0 | 0.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.1 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.0 | 0.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.0 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.0 | 0.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.0 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.3 | GO:0044243 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.0 | 0.1 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.1 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.1 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.0 | 0.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.2 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.0 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.0 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.0 | 0.0 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.0 | GO:1903960 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.0 | 0.0 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.0 | 0.0 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.1 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.0 | GO:0034766 | negative regulation of ion transmembrane transport(GO:0034766) negative regulation of calcium ion import(GO:0090281) negative regulation of cation transmembrane transport(GO:1904063) |
0.0 | 0.0 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.0 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.0 | 0.0 | GO:0048333 | mesodermal cell fate commitment(GO:0001710) mesodermal cell differentiation(GO:0048333) |
0.0 | 0.2 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.0 | 0.0 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.0 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.3 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.0 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.0 | 0.0 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.0 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.0 | 0.0 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.0 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.0 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.1 | 0.9 | GO:0043256 | laminin complex(GO:0043256) |
0.1 | 2.2 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.4 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.3 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.6 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.1 | 0.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.5 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.2 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.4 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 1.4 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.1 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 6.2 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.2 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.1 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.2 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 1.7 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 1.4 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.0 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 1.1 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.9 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.0 | 0.1 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.0 | 0.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.2 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 1.2 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.0 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.1 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.0 | 0.2 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.2 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.0 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.2 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.0 | 0.1 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.0 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 0.6 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.2 | 0.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 1.2 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 0.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.5 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 0.6 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.5 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.3 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 1.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.5 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.5 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.4 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.1 | 0.4 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.2 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.3 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.2 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.1 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.7 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.6 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.2 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.1 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.1 | 0.2 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.5 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 1.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.3 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.1 | 0.2 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.1 | 0.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.3 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.2 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.2 | GO:0051637 | obsolete Gram-positive bacterial cell surface binding(GO:0051637) |
0.0 | 0.8 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.0 | 0.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.6 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 0.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.4 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.4 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.3 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 1.1 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 1.0 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.1 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.4 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 1.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 1.4 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.0 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.6 | GO:0004601 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.3 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.0 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.1 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.0 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.1 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 0.0 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.1 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.0 | 0.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.3 | GO:0019209 | kinase activator activity(GO:0019209) |
0.0 | 0.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 4.2 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.0 | 0.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.0 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.0 | 0.0 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.0 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.0 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.0 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 1.1 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.0 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 0.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.0 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.5 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.0 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 1.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.6 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 1.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 5.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.9 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 4.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 1.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.1 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 1.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 1.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 1.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.4 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 0.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 2.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.4 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 0.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 1.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.4 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 0.4 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 1.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.0 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 0.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.1 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.0 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.0 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 0.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.0 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.0 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.1 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.0 | 0.0 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |